Condensed Consolidated Statements of Shareholders’ Equity (Deficit) (Unaudited) - USD ($) shares in Millions, $ in Millions		Total	Ordinary Shares and Additional Paid-in Capital	Accumulated Deficit	Accumulated  Other Comprehensive Loss, Net of Tax	Non- redeemable Non- controlling Interests
Beginning balance (in shares) at Dec. 31, 2022			205.4
Beginning balance at Dec. 31, 2022		$ (429)	$ 6,866	$ (2,772)	$ (4,623)	$ 100
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,079		1,050		29
Shares issued - employee stock compensation plans (in shares)			0.9
Shares issued - employee stock compensation plans		(132)	$ (131)	(1)
Shares repurchased (in shares)			(1.8)
Shares repurchased		(550)		(550)
Share-based compensation expense		127	$ 127
Dividends to shareholders		(115)		(115)
Net change in fair value of financial instruments		3			3
Net foreign currency translation adjustments		54			54
Net postretirement benefit obligation		22			22
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(1)				(1)
Ending balance (in shares) at Mar. 31, 2023			204.5
Ending balance at Mar. 31, 2023		58	$ 6,862	(2,388)	(4,544)	128
Beginning balance (in shares) at Dec. 31, 2022			205.4
Beginning balance at Dec. 31, 2022		(429)	$ 6,866	(2,772)	(4,623)	100
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,654
Net change in fair value of financial instruments		11
Net foreign currency translation adjustments		228
Net postretirement benefit obligation		46
Ending balance (in shares) at Jun. 30, 2023			203.2
Ending balance at Jun. 30, 2023		162	$ 6,908	(2,505)	(4,338)	97
Beginning balance (in shares) at Mar. 31, 2023			204.5
Beginning balance at Mar. 31, 2023		58	$ 6,862	(2,388)	(4,544)	128
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		575		560		15
Shares issued - employee stock compensation plans (in shares)			0.4
Shares issued - employee stock compensation plans		(52)	$ (52)
Shares repurchased (in shares)			(1.7)
Shares repurchased		(550)		(550)
Share-based compensation expense		99	$ 99
Dividends to shareholders		(127)		(127)
Net change in fair value of financial instruments		8			8
Net foreign currency translation adjustments		174			174
Net postretirement benefit obligation		24			24
Purchases of subsidiary shares from nonredeemable noncontrolling interests		(2)	$ (1)			(1)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(45)				(45)
Ending balance (in shares) at Jun. 30, 2023			203.2
Ending balance at Jun. 30, 2023		$ 162	$ 6,908	(2,505)	(4,338)	97
Beginning balance (in shares) at Dec. 31, 2023		198.6	198.6
Beginning balance at Dec. 31, 2023		$ (742)	$ 6,946	(3,399)	(4,373)	84
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,093		1,071		22
Shares issued - employee stock compensation plans (in shares)			0.8
Shares issued - employee stock compensation plans		(104)	$ (104)
Shares repurchased (in shares)			(0.8)
Shares repurchased		(250)		(250)
Share-based compensation expense		130	$ 130
Dividends to shareholders		(122)		(122)
Net change in fair value of financial instruments		75			75
Net foreign currency translation adjustments		(132)			(132)
Net postretirement benefit obligation		26			26
Purchases of subsidiary shares from nonredeemable noncontrolling interests		(1)	$ (1)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(1)				(1)
Ending balance (in shares) at Mar. 31, 2024			198.6
Ending balance at Mar. 31, 2024		$ (28)	$ 6,971	(2,700)	(4,404)	105
Beginning balance (in shares) at Dec. 31, 2023		198.6	198.6
Beginning balance at Dec. 31, 2023		$ (742)	$ 6,946	(3,399)	(4,373)	84
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,631
Net change in fair value of financial instruments		76
Net foreign currency translation adjustments		(220)
Net postretirement benefit obligation		$ 39
Ending balance (in shares) at Jun. 30, 2024		217.2	217.2
Ending balance at Jun. 30, 2024		$ 6,028	$ 12,912	(2,574)	(4,478)	168
Beginning balance (in shares) at Mar. 31, 2024			198.6
Beginning balance at Mar. 31, 2024		(28)	$ 6,971	(2,700)	(4,404)	105
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		538
Net income	[1]	536		524		12
Shares issued - NFP Transaction (in shares)			19.0
Shares issued - NFP Transaction		5,882	$ 5,882
Shares issued - employee stock compensation plans (in shares)			0.4
Shares issued - employee stock compensation plans		(45)	$ (45)
Shares repurchased (in shares)			(0.8)
Shares repurchased		(250)		(250)
Share-based compensation expense		117	$ 117
Dividends to shareholders		(148)		(148)
Net change in fair value of financial instruments		1			1
Net foreign currency translation adjustments		(88)			(88)
Net postretirement benefit obligation		13			13
Purchases of subsidiary shares from nonredeemable noncontrolling interests		86				86
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(35)				(35)
Adjustments to redeemable noncontrolling interests		$ (13)	$ (13)
Ending balance (in shares) at Jun. 30, 2024		217.2	217.2
Ending balance at Jun. 30, 2024		$ 6,028	$ 12,912	$ (2,574)	$ (4,478)	$ 168

[1] The Company’s Net income totaled $538 million for the quarter ended June 30, 2024, which included $2 million of Net income related to redeemable noncontrolling interests.